Based on this, a CLIF-C ACLF-D score was developed to predict a group of patients with ACLF within 3 months after AD, which included age, ascites, serum white blood cell count, albumin, bilirubin, and creatinine levels. This evidence concerns the gene ALB and Alzheimer disease.